InsidersTradesSigma
Devyser Diagnostics AB: directors' dealings · Finland · FIN-FSA
FI:devyser-diagnostics-abSE0016588867FI·FIN-FSAMcap 1.5Bn€Healthcare
Explore the full insider trade history of Devyser Diagnostics AB, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Devyser Diagnostics AB has published 5 insider filings. Market capitalisation: €1.5bn. The latest transaction was reported on 22 May 2026 (Purchase). Among the most active insiders: Mia Arnhult. The full history is free.
5
Insider Decl.
0
Thresholds
€195,171
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
90.10 €
Analyst consensus
3 analystsStrong buy
141.55 €Target 152.94 €(+70%)165.81 €
Income statement
Revenue250.5 M€
Gross profit201.9 M€81% margin
Net income−8.4 M€5.8% margin
Valuation
PER (trailing)100.1x
PER (forward)28.5x
P/Book4.2x
Beta0.82
Balance sheet & cash
Market cap1.51 Bn€
Total debt51.9 M€
Free Cash Flow−62.0 M€
Debt / Equity14%
Profitability & ownership
ROE4.4%
ROA4.7%
% insiders30.0%
% institutions47.7%
Last declaration on 22 May 2026
Declarations0 total
No declarations found
0 of 0 declarations